These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 18346788)
21. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody. Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407 [TBL] [Abstract][Full Text] [Related]
22. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution. Mylvaganam SE; Paterson Y; Getzoff ED J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550 [TBL] [Abstract][Full Text] [Related]
23. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope. Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016 [TBL] [Abstract][Full Text] [Related]
24. [One amino acid mutation in an anti-CD20 antibody fragment that affects the yield bacterial secretion and the affinity]. Liu YX; Xiong DS; Fan DM; Shao XF; Xu YF; Zhu ZP; Yang CZ Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):272-6. PubMed ID: 15969005 [TBL] [Abstract][Full Text] [Related]
25. Molecular basis for the binding polyspecificity of an anti-cholera toxin peptide 3 monoclonal antibody. Otte L; Knaute T; Schneider-Mergener J; Kramer A J Mol Recognit; 2006; 19(1):49-59. PubMed ID: 16273596 [TBL] [Abstract][Full Text] [Related]
26. Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity. Liu AY; Robinson RR; Murray ED; Ledbetter JA; Hellström I; Hellström KE J Immunol; 1987 Nov; 139(10):3521-6. PubMed ID: 3119711 [TBL] [Abstract][Full Text] [Related]
27. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site. Julien JP; Bryson S; Nieva JL; Pai EF J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005 [TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies against an identical short peptide sequence shared by two unrelated proteins. Schulze-Gahmen U; Wilson IA Pept Res; 1989; 2(5):322-31. PubMed ID: 2485209 [TBL] [Abstract][Full Text] [Related]
29. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies. Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806 [TBL] [Abstract][Full Text] [Related]
30. The epitope recognized by rituximab. Binder M; Otto F; Mertelsmann R; Veelken H; Trepel M Blood; 2006 Sep; 108(6):1975-8. PubMed ID: 16705086 [TBL] [Abstract][Full Text] [Related]
32. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6. Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506 [TBL] [Abstract][Full Text] [Related]
33. Structural evidence for recognition of a single epitope by two distinct antibodies. Fleury D; Daniels RS; Skehel JJ; Knossow M; Bizebard T Proteins; 2000 Sep; 40(4):572-8. PubMed ID: 10899782 [TBL] [Abstract][Full Text] [Related]
34. Crystal structure of an antigen-binding fragment bound to single-stranded DNA. Tanner JJ; Komissarov AA; Deutscher SL J Mol Biol; 2001 Dec; 314(4):807-22. PubMed ID: 11733999 [TBL] [Abstract][Full Text] [Related]
35. The crystal structure of the antibody N10-staphylococcal nuclease complex at 2.9 A resolution. Bossart-Whitaker P; Chang CY; Novotny J; Benjamin DC; Sheriff S J Mol Biol; 1995 Nov; 253(4):559-75. PubMed ID: 7473734 [TBL] [Abstract][Full Text] [Related]
36. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism. Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085 [TBL] [Abstract][Full Text] [Related]
37. Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies. Niederfellner G; Lammens A; Mundigl O; Georges GJ; Schaefer W; Schwaiger M; Franke A; Wiechmann K; Jenewein S; Slootstra JW; Timmerman P; Brännström A; Lindstrom F; Mössner E; Umana P; Hopfner KP; Klein C Blood; 2011 Jul; 118(2):358-67. PubMed ID: 21444918 [TBL] [Abstract][Full Text] [Related]
38. X-ray structure of the uncomplexed anti-tumor antibody BR96 and comparison with its antigen-bound form. Sheriff S; Chang CY; Jeffrey PD; Bajorath J J Mol Biol; 1996 Jun; 259(5):938-46. PubMed ID: 8683596 [TBL] [Abstract][Full Text] [Related]
39. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases. Perosa F; Favoino E; Caragnano MA; Dammacco F Ann N Y Acad Sci; 2005 Jun; 1051():672-83. PubMed ID: 16127008 [TBL] [Abstract][Full Text] [Related]
40. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis. Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]